ArticleBMC gastroenterology2025
Diagnosis and treatment of hemothorax following local ablation in patients with primary liver cancer.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Life-threatening hemothorax after radiofrequency ablation for subcapsular hepatocellular carcinoma in a patient with previous rib injury.Radiology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the diagnosis and treatment methods for hemothorax resulting from local ablation in patients with primary liver cancer.
methodsA retrospective analysis was conducted on the clinical data of patients who underwent hemothorax after local ablation for liver cancer at the Center for Hepatology and Oncology Interventional Therapy, Beijing You’an Hospital, from January 2022 to December 2023. The study focused on the diagnosis and treatment of postoperative hemothorax, evaluating the effectiveness and safety of these methods.
resultsSeven patients developed postoperative hemothorax after local ablation for liver cancer. Of these, 2 patients achieved hemostasis through symptomatic conservative treatment, while 5 required emergency transcatheter arterial embolization due to active bleeding. All patients recovered and were discharged without severe complications.
conclusionHemothorax is a rare but potentially serious complication following liver cancer ablation. Early diagnosis and timely, effective hemostatic intervention are crucial for a favorable prognosis. Interventional embolization is a safe and effective treatment for active hemothorax post-ablation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.